error fb Gplus IN twitter down-arrow Email Phone Check-Mark padlock circle_arrow minus plus play_btn close Clipboard_Icon Shopping-Cart_Icon Speech_Bubble_Icon Stethoscope_Icon pharmacists menu left-arrow right-arrow facebook search cart

What are the benefits of continuous glucose monitoring (CGM)?

A continuous glucose monitor (CGM) offers individuals with type 1 or type 2 diabetes round-the-clock glucose readings with fewer fingersticks, and depending on the CGM product you choose, none at all.*†  Having this level of ongoing, timely feedback can help users make more informed treatment decisions that may help reduce A1C levels.1

Whether you treat your diabetes with multiple injections or an insulin pump, you can expect wide-ranging health and convenience benefits from using a CGM device, including:

• More insight than monitoring alone
Unlike a single reading from a blood glucose meter, a CGM provides real-time, dynamic information about the speed and direction (trending higher or lower) of your glucose levels.

• Improved glycemic control
Having continuous feedback on diet, exercise and insulin requirements from a CGM can help you make more informed treatment decisions which can lead to tighter glycemic control than using a blood glucose meter alone.2

• Fast, proactive response
CGM systems take glucose readings every few minutes and allow you to set customizable thresholds with alerts when your readings are out of target range. This means you’ll often know before you begin to feel symptoms and you can proactively respond.

• Fewer fingersticks
CGM devices use tiny sensors to measure glucose levels just beneath the skin. These sensors connect to a transmitter which wirelessly transmits readings to a receiver or a compatible smart device. At any time, you can see your reading with just a glance. No need to interrupt what you’re doing. 

• Fewer worries
Hear from real Dexcom users about the feelings of freedom and control they have using CGM systems.

1 Beck RW, Riddlesworth T, Ruedy K, et al. Effect of Continuous Glucose Monitoring on Glycemic Control in Adults With Type 1 Diabetes Using Insulin Injections: The DIAMOND Randomized Clinical Trial. JAMA. 2017;317(4):371-378. doi:10.1001/jama.2016.19975.
2 Pettus J, Price DA, Edelman SV. How Patients with Type 1 Diabetes Translate Continuous Glucose Monitoring Data into Diabetes Management Decisions. Endocr Pract. 2015; 1-25. 
*Fingersticks required when symptoms or expectations do not match CGM readings.
† Available with the Dexcom G6 CGM System.

General FAQ Topics:

LBL017119 Rev001
US - English translation unavailable for Interested in Dexcom CGM.